JAMA Internal Medicine

An Unexpected Cause of Hypotension
Heath JR, Chang A and Finkbeiner M
Coprescribing GLP-1 Receptor Agonists and Lifestyle
Rockwell MS, Polk EA and Mittendorf C
Oral Corticosteroid Use During Pregnancy and the Risk of Gestational Diabetes
Choi EY, Cho Y, Oh J, Choi A, Kim H and Shin JY
Oral corticosteroids (OCSs) are increasingly used during pregnancy for various conditions due to their immunosuppressive and anti-inflammatory properties. However, OCSs may induce insulin resistance, potentially contributing to gestational diabetes, and limited studies have examined this association.
Coprescribing GLP-1 Receptor Agonists and Lifestyle-Reply
Mehrtash F, Dushay J and Manson JE
Antibiotic Prophylaxis in Patients With Cirrhosis Presenting With Variceal Bleeding-Are We Treating the Past?-Reply
Prosty C, Lee TC and McDonald EG
The Letters Not Sent
Bair H
Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval
Rand LZ, Mooney H, Hong D, Eisenkraft Klein D, Kesselheim AS and Rome BN
Inhaler Price Caps-Patchwork Progress Without Reform
Mein SA and Wadhera RK
Consequences of Grant Termination in Clinical Trials
Brender TD and Gross CP
Implementing Benzodiazepine Deprescribing in the Primary Care Clinic
Shuey B, Anderson TS and Park TW
Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial
Horn DB, Linetzky B, Davies MJ, Laffin LJ, Wang H, Murphy MA, Zimner-Rapuch S, Lau E, Arad AD and Lee CJ
In the SURMOUNT-4 trial, most adults with obesity who had tirzepatide withdrawn following a 36-week treatment regained weight. The association between the degree of weight regain and cardiometabolic parameters after tirzepatide withdrawal is unknown.
Sexual Health in Cancer Care-A Gap in Understanding
Trudeau RK, Gbolahan OB and Pinto Taylor E
Durability of Respiratory Syncytial Virus Vaccine Effectiveness Among US Veterans
Bajema KL, Bui DP, Yan L, Li Y, Rajeevan N, Vergun R, Sriskantharajah V, Hynes DM, Berry K, Huang Y, Lin HM, Aslan M and Ioannou GN
A single respiratory syncytial virus (RSV) vaccine dose is recommended for older adults and persons at increased risk for severe RSV. Clinical information on the long-term effectiveness of RSV vaccines is needed.
Frailty Assessment for Decision-Making in Older Patients With Acute Coronary Syndrome-Reply
Reddy RK, Howard JP and Ahmad Y
An Uncommon Cause of Bradycardia Treated With Catheter Ablation
Lee CH and Gerstenfeld EP
Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approvals
Lee CJ, Gross CP and Miller JE
Populations participating in clinical trials should benefit from resulting interventions, according to ethical guidance. Yet, exploratory studies show low- and middle-income countries (LMICs) participating in trials for US Food and Drug Administration (FDA) approvals lack timely access to the medicines they test, raising exploitation concerns.
The Importance of Real-World Evidence to Inform RSV Vaccine Guidance
Hung A and Mody L
Antibiotic Prophylaxis in Patients With Cirrhosis Presenting With Variceal Bleeding-Are We Treating the Past?
Bot KKIM, de Wit K and Lantinga MA
Frailty Assessment for Decision-Making in Older Patients With Acute Coronary Syndrome
Sanchis J, Bueno H and Ariza-Solé A
US Food and Drug Administration Competitive Generic Therapy Approvals and Drug Competition
Kho K, Patel R and Chahal HS
Lessons Learned From Antiobesity Medication Withdrawal Trials
Oczypok E and Anderson TS